University of Oxford
๐ฌ๐งUnited Kingdom
- Country
- ๐ฌ๐งUnited Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
Oxfordshire Sedentariness, Obesity & Cardiometabolic Risk in Adolescents - a Trial of Exercise in Schools
Not Applicable
- Conditions
- Overweight/Obesity, Adolescent
- Interventions
- Other: Intervention GroupOther: Sham-Exercise Group
- First Posted Date
- 2019-10-08
- Last Posted Date
- 2021-08-12
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 210
- Registration Number
- NCT04118543
- Locations
- ๐ฌ๐ง
Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Oxford, Oxfordshire, United Kingdom
Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.
Phase 2
Completed
- Conditions
- Hepatitis BTenofovirPregnancy
- Interventions
- First Posted Date
- 2019-10-03
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 27
- Registration Number
- NCT04114890
- Locations
- ๐น๐ญ
Shoklo Malaria Research unit (SMRU) clinics, Mae sot, Tak, Thailand
Ciprofloxacin Versus an Aminoglycoside Followed by Ciprofloxacin for Bubonic Plague
Phase 3
Recruiting
- Conditions
- Plague, PneumonicPlague, Bubonic
- Interventions
- First Posted Date
- 2019-10-01
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 463
- Registration Number
- NCT04110340
- Locations
- ๐ฒ๐ฌ
Professor Mamy Randria, Antananarivo, Madagascar
Acute Exacerbations Treated With BenRAlizumab (The ABRA Study)
- First Posted Date
- 2019-09-23
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 158
- Registration Number
- NCT04098718
- Locations
- ๐ฌ๐ง
Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom
Mass Screening and Treatment for Reduction of Falciparum Malaria
Not Applicable
Completed
- Conditions
- Plasmodium Falciparum Malaria
- Interventions
- Diagnostic Test: Ultrasensitive Rapid Diagnostic Test (URDT)Drug: Antimalarials
- First Posted Date
- 2019-09-18
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 5542
- Registration Number
- NCT04093765
- Locations
- ๐น๐ญ
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand
Vivax Malaria Human Infection Studies in Thailand
Not Applicable
Recruiting
- Conditions
- Plasmodium Vivax Infection
- Interventions
- Other: Mosquito bites
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 6
- Registration Number
- NCT04083508
- Locations
- ๐น๐ญ
Faculty of Tropical Medicine, Bangkok, Thailand
Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects
Phase 1
Recruiting
- Conditions
- PharmacokineticHealthyDrug Combination
- Interventions
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 16
- Registration Number
- NCT04080895
- Locations
- ๐น๐ญ
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Using DBS to Probe Basal Ganglia Dysfunction
- Conditions
- Parkinson's DiseaseTremorDystonia
- Interventions
- Other: Feed-back controlled deep brain stimulation
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2019-09-06
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 60
- Registration Number
- NCT04080674
- Locations
- ๐ฌ๐ง
University of Oxford, Oxford, United Kingdom
Sero-epidemiological Survey of England in 2019/2020 - COVID-19
- Conditions
- DiphtheriaSerogroup C Meningococcal MeningitisCOVID-19
- Interventions
- Procedure: VenepunctureProcedure: Oral fluid swab
- First Posted Date
- 2019-08-19
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 2959
- Registration Number
- NCT04061382
- Locations
- ๐ฌ๐ง
Centre for Clinical Vaccinology & Tropical Medicine (CCVTM), Oxford, Oxfordshire, United Kingdom
Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine
Phase 4
Completed
- Conditions
- Yellow Fever
- Interventions
- Biological: Yellow fever vaccine, Institut Pasteur
- First Posted Date
- 2019-08-16
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 900
- Registration Number
- NCT04059471
- Locations
- ๐ฐ๐ช
KEMRI-Wellcome Trust Research Programme, Kilifi, Coast, Kenya
๐บ๐ฌEpicentre, Mbarara., Mbarara, Uganda
ยฉ Copyright 2025. All Rights Reserved by MedPath